The Adult Leukemia Program is part of the Hematologic Oncology (Blood Cancers) Treatment Center. Our specialists are highly experienced in treating patients with acute and chronic leukemia, myeloproliferative disorders and myelodysplastic syndromes.
We provide care for patients with leukemia, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and related bone marrow disorders, including myelodysplasia and myelofibrosis. Our program is one of the most experienced in the nation, with a high volume of consultations, patients cared for, and clinical trials offered. Through our program of clinical research, we apply our ongoing understanding of leukemia to developing therapies that will benefit patients today and in the future.
Our Treatment Approach
The Adult Leukemia Program provides comprehensive services for patients with acute leukemia and related disorders. These include:
- Evaluation and diagnosis of individuals with any type of bone marrow disorder, including acute and chronic leukemias, myelodysplastic syndromes (MDS), and myeloproliferative neoplasms
- Evaluation and diagnosis of patients with unexplained anemia, or abnormal white blood or platelet counts
- Development and implementation of a personalized treatment plan, ranging from standard supportive care to intensive chemotherapy for acute leukemia
- Access to new therapies through clinical trials
- Comprehensive bone marrow/stem cell transplantation services
- Support services
- Access to complementary therapies through the Leonard P. Zakim Center for Integrated Therapies and Healthy Living
- Follow-up care, including collaboration with your local (referring) physician
